Bispecific antibody for target cell-specific stimulation of...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/46 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2416572

The present invention relates to the stimulation of APO-1--dependent cell death only in specific target cells using a bispecific antibody that binds APO-1 and a target cell-specific antigen. Specifically, there is a bispecific antibody fragment which is lacking an Fc moiety wherein the antibody fragment has a monovalent binding side for a death receptor and a binding site for a target antigen wherein the death receptor is APO-1 and the target antigen is selected from the group consisting of tumor cell-specific cell surface antigens, T-cell specific cell surface antigens, CD markers and cell-specific markers.

Un réactif multispécifique (15) présente au moins une première zone de liaison (17) destinée à un récepteur de surface cellulaire (12) dont la stimulation nécessite une liaison de ligands multimère. Le réactif (15) présente une deuxième zone de liaison (16) destinée à un antigène cible (14) exprimé sur la même cellule (10) que le récepteur de surface cellulaire (12).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Bispecific antibody for target cell-specific stimulation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bispecific antibody for target cell-specific stimulation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bispecific antibody for target cell-specific stimulation of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2044695

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.